Planning Strategies Inc.’s Regeneron Pharmaceuticals REGN Stock Holding History

Planning Strategies Inc.’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.74K	Buy	+6	New	+$4.08K	﹤0.01%	459

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MCI

McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

Planning Strategies Inc.'s REGN Position: Q2 2026 in Review

Planning Strategies Inc. opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 6 shares worth $3.74K. The stake represents ﹤0.01% of the portfolio and ranks #459 among its holdings.

454 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Planning Strategies Inc. held 6 shares of Regeneron Pharmaceuticals worth $3.74K as of Q2 2026.
Regeneron Pharmaceuticals was a new Planning Strategies Inc. position in Q2 2026.
Regeneron Pharmaceuticals made up ﹤0.01% of Planning Strategies Inc.'s portfolio in Q2 2026, its #459 holding.
454 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Planning Strategies Inc.'s 13F filing for Q2 2026, filed 27 Jul 2026.